CRL Operational Budgets (2) showing the operational costs of the CRL
CRL-1623
2
Organism: Homo sapiens, human Tissue: tongue Disease: squamous cell carcinoma Age: 55 years Gender: male Growth Properties: adherent DNA Profile: Amelogenin: X,Y CSF1PO: 10,13 D13S317: 9,14 D16S539: 12,15 D5S818: 12 D7S820: 10,11 THO1: 9,9.3 TPOX: 8 vWA: 15,17 Refer to the Certificate of Analysis for batchspecific test results. ATCC highly recommends that protective gloves and clothing always be used and a full face mask always be worn when handling frozen vials. It is important to note that some vials leak when submersed in liquid nitrogen and will slowly fill with liquid nitrogen. Upon thawing, the conversion of the liquid nitrogen back to its gas phase may result in the vessel exploding or blowing off its cap with dangerous force creating flying debris. 1. Check all containers for leakage or breakage. 2. Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below 130°C, preferably in liquid nitrogen vapor, until ready for use. To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at 70°C. Storage at 70°C will result in loss of viability. 1. Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the Oring and cap out of the water. Thawing should be rapid (approximately 2 minutes). 2. Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions. 3. It is recommended that the cryoprotective agent be removed immediately. Centrifuge the cell suspension at approximately 125 x g for 5 to 10 minutes. Discard the supernatant and resuspend the cell pellet in an appropriate amount of fresh growth medium. 4. Transfer the cell pellet to an appropriate size vessel. It is important to avoid excessive alkalinity of the medium during recovery of the cells. It is suggested that, prior to the addition of the vial contents, the culture vessel containing the growth medium be placed into the incubator for at least 15 minutes to allow the medium to reach its normal pH (7.0 to 7.6). 5. Incubate the culture at 37°C in a suitable incubator. A 5% CO 2 in air atmosphere is recommended if using the medium described on this product sheet. The flask was seeded with cells (see specific batch information) grown and completely filled with medium at ATCC to prevent loss of cells during shipping. 1. Upon receipt visually examine the culture for macroscopic evidence of any microbial contamination. Using an inverted microscope (preferably equipped with phasecontrast optics), carefully check for any evidence of microbial contamination. Also check to determine if the majority of cells are still attached to the bottom of the flask; during shipping the cultures are sometimes handled roughly and Description BatchSpecific Information SAFETY PRECAUTION Unpacking & Storage Instructions Handling Procedure for Frozen Cells Handling Procedure for Flask Cultures Page 1 of 2 Product Sheet SCC15 (ATCC ® CRL1623 ™ ) Please read this FIRST Storage Temp. Liquid nitrogen vapor phase Biosafety Level 1 Intended Use This product is intended for research use only. It is not intended for any animal or human therapeutic or diagnostic use. Complete Growth Medium A 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F12 medium containing 1.2 g/L sodium bicarbonate, 2.5 mM Lglutamine, 15 mM HEPES and 0.5 mM sodium pyruvate supplemented with 400 ng/ml hydrocortisone, 90%; fetal bovine serum, 10% Citation of Strain If use of this culture results in a scientific publication, it should be cited in that manuscript in the following manner: SCC15 (ATCC ® CRL1623 ™ ) American Type Culture Collection PO Box 1549 Manassas, VA 20108 USA www.atcc.org 800.638.6597 or 703.365.2700 Fax: 703.365.2750 Email: [email protected] Or contact your local distributor
-
Upload
glauce-l-trevisan -
Category
Documents
-
view
217 -
download
0
description
artigo
Transcript of CRL-1623
-
Organism:Homosapiens,humanTissue:tongueDisease:squamouscellcarcinomaAge:55yearsGender:maleGrowthProperties:adherentDNAProfile:Amelogenin:X,YCSF1PO:10,13D13S317:9,14D16S539:12,15D5S818:12D7S820:10,11THO1:9,9.3TPOX:8vWA:15,17
RefertotheCertificateofAnalysisforbatchspecifictestresults.
ATCChighlyrecommendsthatprotectiveglovesandclothingalwaysbeusedandafullfacemaskalwaysbewornwhenhandlingfrozenvials.Itisimportanttonotethatsomevialsleakwhensubmersedinliquidnitrogenandwillslowlyfillwithliquidnitrogen.Uponthawing,theconversionoftheliquidnitrogenbacktoitsgasphasemayresultinthevesselexplodingorblowingoffitscapwithdangerousforcecreatingflyingdebris.
1. Checkallcontainersforleakageorbreakage.2. Removethefrozencellsfromthedryicepackagingandimmediatelyplacethecellsatatemperature
below130C,preferablyinliquidnitrogenvapor,untilreadyforuse.
Toinsurethehighestlevelofviability,thawthevialandinitiatethecultureassoonaspossibleuponreceipt.Ifuponarrival,continuedstorageofthefrozencultureisnecessary,itshouldbestoredinliquidnitrogenvaporphaseandnotat70C.Storageat70Cwillresultinlossofviability.
1. Thawthevialbygentleagitationina37Cwaterbath.Toreducethepossibilityofcontamination,keeptheOringandcapoutofthewater.Thawingshouldberapid(approximately2minutes).
2. Removethevialfromthewaterbathassoonasthecontentsarethawed,anddecontaminatebydippinginorsprayingwith70%ethanol.Alloftheoperationsfromthispointonshouldbecarriedoutunderstrictasepticconditions.
3. Itisrecommendedthatthecryoprotectiveagentberemovedimmediately.Centrifugethecellsuspensionatapproximately125xgfor5to10minutes.Discardthesupernatantandresuspendthecellpelletinanappropriateamountoffreshgrowthmedium.
4. Transferthecellpellettoanappropriatesizevessel.Itisimportanttoavoidexcessivealkalinityofthemediumduringrecoveryofthecells.Itissuggestedthat,priortotheadditionofthevialcontents,theculturevesselcontainingthegrowthmediumbeplacedintotheincubatorforatleast15minutestoallowthemediumtoreachitsnormalpH(7.0to7.6).
5. Incubatethecultureat37Cinasuitableincubator.A5%CO2inairatmosphereisrecommendedifusingthemediumdescribedonthisproductsheet.
Theflaskwasseededwithcells(seespecificbatchinformation)grownandcompletelyfilledwithmediumatATCCtopreventlossofcellsduringshipping.
1. Uponreceiptvisuallyexaminethecultureformacroscopicevidenceofanymicrobialcontamination.Usinganinvertedmicroscope(preferablyequippedwithphasecontrastoptics),carefullycheckforanyevidenceofmicrobialcontamination.Alsochecktodetermineifthemajorityofcellsarestillattachedtothebottomoftheflaskduringshippingtheculturesaresometimeshandledroughlyand
Description
BatchSpecificInformation
SAFETYPRECAUTION
Unpacking&StorageInstructions
HandlingProcedureforFrozenCells
HandlingProcedureforFlaskCultures
Page1of2
ProductSheet
SCC15(ATCCCRL1623)
PleasereadthisFIRST
StorageTemp.Liquidnitrogenvaporphase
BiosafetyLevel1
IntendedUse
Thisproductisintendedforresearchuseonly.Itisnotintendedforanyanimalorhumantherapeuticordiagnosticuse.
CompleteGrowthMedium
A1:1mixtureofDulbecco'smodifiedEagle'smediumandHam'sF12mediumcontaining1.2g/Lsodiumbicarbonate,2.5mMLglutamine,15mMHEPESand0.5mMsodiumpyruvatesupplementedwith400ng/mlhydrocortisone,90%fetalbovineserum,10%
CitationofStrain
Ifuseofthiscultureresultsinascientificpublication,itshouldbecitedinthatmanuscriptinthefollowingmanner:SCC15(ATCCCRL1623)
AmericanTypeCultureCollectionPOBox1549Manassas,VA20108USAwww.atcc.org
800.638.6597or703.365.2700Fax:703.365.2750Email:[email protected]
-
manyofthecellsoftendetachandbecomesuspendedintheculturemedium(butarestillviable).2. Ifthecellsarestillattached,asepticallyremoveallbut5to10mLoftheshippingmedium.The
shippingmediumcanbesavedforreuse.Incubatethecellsat37Cina5%CO2inairatmosphereuntiltheyarereadytobesubcultured.
3. Ifthecellsarenotattached,asepticallyremovetheentirecontentsoftheflaskandcentrifugeat125xgfor5to10minutes.Removeshippingmediumandsave.Resuspendthepelletedcellsin10mLofthismediumandaddto25cm2flask.Incubateat37Cina5%CO2inairatmosphereuntilcellsarereadytobesubcultured.
Removemedium,andrinsewith0.25%trypsin,0.03%EDTAsolution.Removethesolutionandaddanadditional1to2mLoftrypsinEDTAsolution.Allowtheflasktositatroomtemperature(orat37C)untilthecellsdetach.Addfreshculturemedium,aspirateanddispenseintonewcultureflasks.SubcultivationRatio:Asubcultivationratioof1:4to1:8isrecommendedMediumRenewal:Every2to3days
Completegrowthmediumdescribedabovesupplementedwith5%(v/v)DMSO.CellculturetestedDMSOisavailableasATCCCatalogNo.4X.
UnlikeSCC4(ATCCCRL1624),thislinedoesnotgrowwellinsemisolidmedium,anddoesnotrequireafeederlayer.
Referencesandotherinformationrelatingtothisproductareavailableonlineatwww.atcc.org.
Appropriatesafetyproceduresshouldalwaysbeusedwiththismaterial.LaboratorysafetyisdiscussedinthecurrentpublicationoftheBiosafetyinMicrobiologicalandBiomedicalLaboratoriesfromtheU.S.DepartmentofHealthandHumanServicesCentersforDiseaseControlandPreventionandNationalInstitutesforHealth.
ATCCWarranty
TheviabilityofATCCproductsiswarrantedfor30daysfromthedateofshipment,andisvalidonlyiftheproductisstoredandculturedaccordingtotheinformationincludedonthisproductinformationsheet.ATCCliststhemediaformulationthathasbeenfoundtobeeffectiveforthisstrain.Whileother,unspecifiedmediamayalsoproducesatisfactoryresults,achangeinmediaortheabsenceofanadditivefromtheATCCrecommendedmediamayaffectrecovery,growthand/orfunctionofthisstrain.Ifanalternativemediumformulationisused,theATCCwarrantyforviabilityisnolongervalid.
Disclaimers
Thisproductisintendedforlaboratoryresearchpurposesonly.Itisnotintendedforuseinhumans.WhileATCCusesreasonableeffortstoincludeaccurateanduptodateinformationonthisproductsheet,ATCCmakesnowarrantiesorrepresentationsastoitsaccuracy.Citationsfromscientificliteratureandpatentsareprovidedforinformationalpurposesonly.ATCCdoesnotwarrantthatsuchinformationhasbeenconfirmedtobeaccurate.Thisproductissentwiththeconditionthatyouareresponsibleforitssafestorage,handling,anduse.ATCCisnotliableforanydamagesorinjuriesarisingfromreceiptand/oruseofthisproduct.Whilereasonableeffortismadetoinsureauthenticityandreliabilityofstrainsondeposit,ATCCisnotliablefordamagesarisingfromthemisidentificationormisrepresentationofcultures.PleaseseetheenclosedMaterialTransferAgreement(MTA)forfurtherdetailsregardingtheuseofthisproduct.TheMTAisalsoavailableonourWebsiteatwww.atcc.org
AdditionalinformationonthiscultureisavailableontheATCCwebsiteatwww.atcc.org.ATCC2013.Allrightsreserved.ATCCisaregisteredtrademarkoftheAmericanTypeCultureCollection.[06/03]
SubculturingProcedure
CryopreservationMedium
Comments
References
BiosafetyLevel:1
Page2of2
ProductSheet
SCC15(ATCCCRL1623)
PleasereadthisFIRST
StorageTemp.Liquidnitrogenvaporphase
BiosafetyLevel1
IntendedUse
Thisproductisintendedforresearchuseonly.Itisnotintendedforanyanimalorhumantherapeuticordiagnosticuse.
CompleteGrowthMedium
A1:1mixtureofDulbecco'smodifiedEagle'smediumandHam'sF12mediumcontaining1.2g/Lsodiumbicarbonate,2.5mMLglutamine,15mMHEPESand0.5mMsodiumpyruvatesupplementedwith400ng/mlhydrocortisone,90%fetalbovineserum,10%
CitationofStrain
Ifuseofthiscultureresultsinascientificpublication,itshouldbecitedinthatmanuscriptinthefollowingmanner:SCC15(ATCCCRL1623)
AmericanTypeCultureCollectionPOBox1549Manassas,VA20108USAwww.atcc.org
800.638.6597or703.365.2700Fax:703.365.2750Email:[email protected]
![William Shakespeare, Cymbeline [1623]](https://static.fdocuments.us/doc/165x107/577d397a1a28ab3a6b99d360/william-shakespeare-cymbeline-1623.jpg)
![William Shakespeare, Othello, The Moore of Venice (Facs. 1st Folio 1623) [1623]](https://static.fdocuments.us/doc/165x107/577d397a1a28ab3a6b99d363/william-shakespeare-othello-the-moore-of-venice-facs-1st-folio-1623-1623.jpg)
